for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Medtronic PLC

MDT.N

Latest Trade

91.67USD

Change

-1.54(-1.65%)

Volume

1,351,838

Today's Range

91.50

 - 

92.83

52 Week Range

72.16

 - 

122.06

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
93.21
Open
92.07
Volume
1,351,838
3M AVG Volume
131.10
Today's High
92.83
Today's Low
91.50
52 Week High
122.06
52 Week Low
72.16
Shares Out (MIL)
1,341.30
Market Cap (MIL)
124,955.40
Forward P/E
25.73
Dividend (Yield %)
2.49

Next Event

Q1 2021 Medtronic PLC Earnings Release

Latest Developments

More

ABRE Study Meets Primary Safety And Effectiveness Endpoints

Medtronic Announces A $337 Mln Product Investment From Blackstone Life Sciences To Expand Development Of Future Diabetes Technologies

Titan Medical Reports Development And License Agreements With Medtronic

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Medtronic PLC

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The Company's subsidiaries include Medtronic, Inc. and HeartWare International, Inc.

Industry

Medical Equipment & Supplies

Contact Info

20 On Hatch, Hatch Street Lower

2

Ireland

+353.1.4381700

http://www.medtronic.com/

Executive Leadership

Omar Syed Ishrak

Executive Chairman of the Board

Geoffrey S. Martha

President, Chief Executive Officer, Director

Karen L. Parkhill

Chief Financial Officer, Executive Vice President

Carol A. Surface

Chief Human Resource Officer, Senior Vice President

Michael J. Coyle

Executive Vice President, Group President - Cardiac and Vascular Group

Key Stats

2.04 mean rating - 27 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

30.0K

2019

30.6K

2020

28.9K

2021(E)

27.8K
EPS (USD)

2018

4.770

2019

5.220

2020

4.590

2021(E)

3.620
Price To Earnings (TTM)
26.64
Price To Sales (TTM)
4.32
Price To Book (MRQ)
2.46
Price To Cash Flow (TTM)
16.87
Total Debt To Equity (MRQ)
48.87
LT Debt To Equity (MRQ)
43.40
Return on Investment (TTM)
5.88
Return on Equity (TTM)
5.26

Latest News

Latest News

BRIEF-Medtronic Introduces Minimed Mio Advance Infusion Set Enabling Fewer Insertion Steps For People With Diabetes In U.S.

* MEDTRONIC INTRODUCES MINIMED™ MIO™ ADVANCE INFUSION SET ENABLING FEWER INSERTION STEPS FOR PEOPLE WITH DIABETES IN THE U.S. Source text for Eikon: Further company coverage:

BRIEF-Medtronic Gains FDA Clearance, CE Mark For Linq II™ Insertable Cardiac Monitor

* MEDTRONIC GAINS FDA CLEARANCE, CE MARK FOR LINQ II™ INSERTABLE CARDIAC MONITOR (ICM) Source text for Eikon: Further company coverage:

BRIEF-Medtronic Begins Real-World Post-Market Study Of The Valiant Navion Thoracic Stent Graft System

* MEDTRONIC BEGINS REAL-WORLD POST-MARKET STUDY OF THE VALIANT NAVION THORACIC STENT GRAFT SYSTEM IN PATIENTS WITH THORACIC AORTIC DISSECTION Source text for Eikon: Further company coverage:

BRIEF-New Real-World Data From Medtronic Global SYMPLICITY Registry Show Renal Denervation Lowered Blood Pressure In Patients With Hypertension Out To 3 Years

* NEW REAL-WORLD DATA FROM MEDTRONIC GLOBAL SYMPLICITY REGISTRY SHOW RENAL DENERVATION LOWERED BLOOD PRESSURE IN PATIENTS WITH HYPERTENSION OUT TO THREE YEARS

Medtronic ties up with Foxconn to boost ventilator production

Medtronic said on Thursday it had partnered with Foxconn to boost production of its ventilators to 10,000 over the next year amid surging demand as the respiratory disease caused by the new coronavirus overwhelms hospitals.

Medtronic partners with Foxconn to boost ventilator production

Medical device maker Medtronic said on Thursday it had partnered with Foxconn to increase production of its ventilators that are critical in the care of patients with COVID-19. (Reporting by Manas Mishra in Bengaluru; Editing by Aditya Soni)

BRIEF-Medtronic And Foxconn Partner To Increase Ventilator Production

* MEDTRONIC AND FOXCONN PARTNER TO INCREASE VENTILATOR PRODUCTION Source text for Eikon: Further company coverage:

BRIEF-Medtronic And Foxconn Partner To Increase Ventilator Production

* MEDTRONIC AND FOXCONN PARTNER TO INCREASE VENTILATOR PRODUCTION

BRIEF-ABRE Study Meets Primary Safety And Effectiveness Endpoints

* ABRE STUDY MEETS PRIMARY SAFETY AND EFFECTIVENESS ENDPOINTS

BRIEF-Medtronic Says Received CE Mark For Micra AV Transcatheter Pacing System

* MEDTRONIC PLC - HAS RECEIVED CE MARK FOR MICRA AV TRANSCATHETER PACING SYSTEM Source text for Eikon: Further company coverage:

BRIEF-Medtronic Announces A $337 Mln Product Investment From Blackstone Life Sciences To Expand Development Of Future Diabetes Technologies

* MEDTRONIC ANNOUNCES A $337 MILLION PRODUCT INVESTMENT FROM BLACKSTONE LIFE SCIENCES TO EXPAND DEVELOPMENT OF FUTURE DIABETES TECHNOLOGIES

BRIEF-Medtronic Presents U.S. Pivotal Trial Data For Minimed 780G Advanced Hybrid Closed Loop System With Automated Correction Bolus Feature

* MEDTRONIC PRESENTS U.S. PIVOTAL TRIAL DATA FOR MINIMED™ 780G ADVANCED HYBRID CLOSED LOOP SYSTEM WITH AUTOMATED CORRECTION BOLUS FEATURE

BRIEF-Medtronic Secures CE Mark For MiniMed 780G System Designed to Simplify Type 1 Diabetes Management

* MEDTRONIC SECURES CE MARK FOR MINIMED™ 780G ADVANCED HYBRID CLOSED LOOP SYSTEM DESIGNED TO FURTHER SIMPLIFY TYPE 1 DIABETES MANAGEMENT

BRIEF-Medtronic Secures CE Mark For MiniMed 780G Advanced Hybrid Closed Loop System

* MEDTRONIC - SECURES CE MARK FOR MINIMED 780G ADVANCED HYBRID CLOSED LOOP SYSTEM DESIGNED TO FURTHER SIMPLIFY TYPE 1 DIABETES MANAGEMENT

BRIEF-Medtronic Resolute Onyx Des Receives First And Only One-Month DAPT Indication For High Bleeding Risk Patients In Europe

* MEDTRONIC RESOLUTE ONYX™ DES RECEIVES FIRST AND ONLY ONE-MONTH DAPT INDICATION FOR HIGH BLEEDING RISK PATIENTS IN EUROPE

BRIEF-Titan Medical Reports Development And License Agreements With Medtronic

* TITAN MEDICAL ANNOUNCES DEVELOPMENT AND LICENSE AGREEMENTS WITH MEDTRONIC AND SENIOR SECURED LOAN

BRIEF-Medtronic PLC Announced U.S. FDA Approval For Android Version Of Its Guardian Connect Continuous Glucose Monitoring System

* MEDTRONIC PLC - ANNOUNCED U.S. FDA APPROVAL FOR ANDROID™ VERSION OF ITS GUARDIAN™ CONNECT CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM Source text for Eikon: Further company coverage:

BRIEF-Medtronic PLC Says Seeing Earlier-Than-Expected Signs Of Recovery In Parts Of The World For Medical Procedures Conf. Call

* MEDTRONIC PLC SAYS SEEING EARLIER-THAN-EXPECTED SIGNS OF RECOVERY IN PARTS OF THE WORLD FOR MEDICAL PROCEDURES: CONF. CALL Further company coverage:

Medtronic warns of sales hit as people delay non-emergency surgeries

Medical device maker Medtronic Plc <MDT.N> warned of a significant hit to current-quarter sales on Thursday as Americans are forced to delay less urgent surgeries because of the COVID-19 pandemic, sending its shares down 2%.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up